Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Exploring how HPMA copolymer drug bioconjugates can deliver Bcl-2 inhibitor HA14-1 to revolutionize cancer treatment through targeted therapy.